Could this be the secret to Pfizer's rebound strategy?

Pfizer’s CEO, Albert Bourla, Ph.D., has yet to top the $33 million in compensation that he earned on the coattails of megablockbuster COVID-19 sales in 2022, but a $27.6 million pay package after a ...

The building on East 42nd Street, the former headquarters of Pfizer, was being converted to apartments. Several upper floors ...

A 7% dividend yield will grab your attention, but be sure to read the fine print.

The sizable yield comes with a concerning footnote. Just look at the rest of the story.

Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday. President Trump and Pfizer announced a deal to cut drug pricing yesterday. And it looks ...

Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer's stock is up by more than 10% this year, while AbbVie's shares have ...

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk ...

A recent study pinpoints the two leading GLP-1 manufacturers as the top pharma companies cited the most across leading AI ...